RUNX1 and acute myeloid leukemia: ADAR2 suppresses leukemogenesis specifically in t(8;21) and inv16 AML cells by the RUNX1-ETO AE9a fusion protein, targeting COPA and COG3 to inhibit clonogenic growth of human t(8;21) AML cells